Nicotine Polacrilex

尼古丁香糖

Report date: 2022/02/10 09:41:26
NME

Base Information

Drug NameNicotine Polacrilex
Drug Alias Name尼古丁口香糖戒烟口香糖NicoretteNicotine Polacrilex
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionNeuronal acetylcholine receptor; alpha4/beta2 agonists
TargetsNeuronal acetylcholine receptor alpha4/beta2 complex
Therapy Area/IndicationsDepressive DisorderCigarette SmokingSmoking +[11] 
Global Approved IndicationsSmoking Cessation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/01/13
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLC
Inactive CompaniesWake Forest University Health SciencesYale UniversityBrown University +[8] 
Active IndicationsSmoking Cessation
Inactive IndicationsDepressive DisorderCigarette SmokingSmoking +[10] 

Other Information

ATC CodeN07BA01
Related LinksWikipediaDrugBankKEGG